Ambroxol reduces LPS toxicity mediated by induction of alkaline phosphatases in rat lung.
Alkaline phosphatases (APs) have been suggested to detoxify lipopolysaccharide (LPS) by dephosphorylation. Ambroxol, a bronchial expectorant, is known to accelerate the secretion of pulmonary surfactant particles including AP molecules as a pharmacological action. In the present study, some beneficial effects of ambroxol on LPS toxicity in the rat lung were investigated. In an experiment using the rat lung organ culture, AP activities were enhanced in a time-dependent manner by incubation with 25 microM of ambroxol in both the tissue and the medium. Western blot analysis indicated that AP activity was elevated by the treatment with ambroxol, due to the induction of surfactant proteins (SPs) and AP molecules. In the in vivo experiment, the serum LPS content was markedly increased after LPS administration to rats by intratracheal instillation of 20 mg/kg. However, when the rats were pretreated with oral ambroxol (1.0 mg/kg) at 1 h before LPS challenge, the area under the concentration--time curve (AUC) of serum LPS was significantly decreased. These results suggest that ambroxol inhibits the translocation of LPS from the lung into the circulation as well as its detoxification effect via the elevation of AP activity. Bromhexine, another expectorant, is less effective than ambroxol as an LPS detoxificant. Maintenance of high AP activity level in the lung suggests APs to have physiological significant effects against the inflammatory events induced by LPS.
Department of Medical Technology, Junior College, Saitama Medical School, Moroyama, Iruma, Saitama, Japan. koyamaw@saitama-med.ac.jp
Iwao
I
Koyama
Toshiyuki
T
Matsunaga
Tsuyoshi
T
Harada
Akira
A
Kikuno
Shigeru
S
Hokari
Tsugikazu
T
Komoda
D000284:Administration, Oral; D000469:Alkaline Phosphatase / Q000378:metabolism*; D000551:Ambroxol / Q000494:pharmacology*; D000818:Animals; D019540:Area Under Curve; D015153:Blotting, Western; D001980:Bronchi / Q000473:pathology; D004305:Dose-Response Relationship, Drug; D005100:Expectorants / Q000494:pharmacology; D008070:Lipopolysaccharides / Q000097:blood / Q000378:metabolism*; D008168:Lung / Q000378:metabolism* / Q000473:pathology; D008297:Male; D009924:Organ Culture Techniques; D010766:Phosphorylation; D051381:Rats; D017208:Rats, Wistar; D013997:Time Factors
D005100:Expectorants; D008070:Lipopolysaccharides; D000551:Ambroxol; D000469:Alkaline Phosphatase